Full name
MEDIKOR III SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
Medikor III
Ujastek 3, 31-752 Kraków
TAX ID7343272374
Rate company:
Medikor III
TAX ID7343272374
Share capital40,000.00 zł
address
Ujastek 3, 31-752 Kraków
Categories
Main category
Register Data
NIP
7343272374
REGON
120575874
KRS
0000492736
Legal form
limited liability company
ALEO.com Registration Date
2014-07-09
Register Address
UL. UJASTEK 3, 31-752 KRAKÓW
Date of registration in KRS
2014-01-08
Date of commencement of economic activity
2014-01-08
Act signature
KR.XI NS-REJ.KRS/3165/20/247/ADE
Pkd codes
86.10.Z - Hospital activities
46.46.Z - Wholesale trade of pharmaceutical and medical products
86.21.Z - General medical practice
86.22.Z - Specialist medical practice
86.90.A - Healthcare
86.90.B - Healthcare
86.90.C - Healthcare
86.90.D - Healthcare
86.90.E - Healthcare
96.04.Z - Individual service activities
Payer VAT status
exempted
Vat list bank account(s)
PL69 1050 1445 1000 0024 5207 0630 
PL77 1050 0086 1000 0024 7756 4476 PL44 1050 1445 1000 0090 3034 8792 PL22 1050 1445 1000 0090 3034 8800 Show more bank accounts from VAT list (1)
Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2021 | 2022 | 2023 | ||
|---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss)  | 3,2 | 1,6 | 4,4 | 175,9 |
EBITDA | 3,7 | 2,1 | 4,4 | 110,2 |
Short time liabilities | 1,5 | 1,7 | 2,8 | 58,5 |
Equity capital | 16,1 | 17,4 | 21 | 20,5 |
Operating profit (EBIT) | 3,1 | 1,5 | 3,8 | 148,2 |
Assets | 18,5 | 20,3 | 24,8 | 22,4 |
Net profit (loss) | 2,6 | 1,3 | 3,6 | 176,1 |
Cash | 0 | 0 | 0 | -24,6 |
Liabilities and provisions for liabilities | 2,3 | 2,8 | 3,8 | 34,3 |
Net income from sale | 25,9 | 26,8 | 32,5 | 21,3 |
Working assets | 12,3 | 14 | 18,8 | 33,8 |
Depreciation | 0,6 | 0,6 | 0,7 | 12,8 |
% | % | % | p.p. | |
Profitability of capital | 16,1 | 7,4 | 17 | 9,6 |
Equity capital to total assets | 87,4 | 86 | 84,6 | -1,4 |
Gross profit margin | 12,3 | 5,9 | 13,5 | 7,6 |
EBITDA Margin | 14,2 | 7,9 | 13,7 | 5,8 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 21 | 24 | 31 | 7 |
Financial statements
01-01-2023 - 31-12-2023
Annual financial report
Download xml01-01-2023 - 31-12-2023
Annual financial report
Download pdf01-01-2023 - 31-12-2023
Activity report
Download pdf01-01-2023 - 31-12-2023
Auditor's opinion / report on the audit of the annual financial statements
Download pdf01-01-2023 - 31-12-2023
Resolution or decision approving the annual financial statements
Download pdf01-01-2023 - 31-12-2023
Resolution on profit distribution or loss coverage
Download pdfShow more (3)
uses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.
